Skip to main content
Medical information Clinical review pending

Genetic Testing

DSG1 Gene Keratosis Palmoplantaris Striata Type 1 Genetic Test

Genetic test using Next Generation Sequencing (NGS) to identify mutations in the DSG1 gene associated with keratosis palmoplantaris striata type 1, a skin condition affecting palms and soles.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (EDTA tube) or saliva sample. Confirm specific requirements with the laboratory before booking.
Results
Confirm turnaround time with the laboratory before booking.
Preparation
No special preparation is typically required for this test. However, confirm with the laboratory for any specific instructions.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the DSG1 Gene Keratosis Palmoplantaris Striata Type 1 Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Symptoms of thickened skin on palms and soles.
  • ✓Presence of painful skin lesions on hands or feet.
  • ✓Family history of keratosis palmoplantaris striata type 1.
  • ✓Diagnosis confirmation for suspected cases.
  • ✓Genetic counseling for affected families.
02

In plain language

What this test helps you understand

This test helps identify specific genetic mutations in the DSG1 gene associated with keratosis palmoplantaris striata type 1. This information can aid in diagnosis, prognosis, and guiding management strategies for individuals with symptoms or a family history of the condition.
The DSG1 Gene Keratosis Palmoplantaris Striata Type 1 NGS Genetic DNA Test is a specialized diagnostic tool used to identify mutations in the DSG1 gene. This gene is linked to keratosis palmoplantaris striata type 1, a condition characterized by skin changes on the palms of the hands and soles of the feet, often causing painful lesions. Understanding your genetic predisposition through this test is important for effective management and treatment planning. This test utilizes advanced Next Generation Sequencing (NGS) technology to analyze your genetic material for specific mutations in the DSG1 gene. Identifying these mutations can help determine if you are predisposed to this condition, which can significantly impact your quality of life. Discussing your results with a healthcare provider or genetic counselor is crucial for understanding the implications and developing appropriate management strategies.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is typically required for this test. However, confirm with the laboratory for any specific instructions.
SampleBlood sample (EDTA tube) or saliva sample. Confirm specific requirements with the laboratory before booking.
MethodologyNext Generation Sequencing (NGS) is used to detect mutations in the DSG1 gene.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test specifically analyzes the DSG1 gene. It does not detect mutations in other genes that might cause similar symptoms. A negative result does not completely rule out a genetic cause for the condition. Results should be interpreted by a qualified healthcare professional.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This is a genetic skin condition affecting the palms and soles, causing thickened skin and often painful lesions.
Individuals with symptoms like thickened skin or painful lesions on palms/soles, or those with a family history of the condition, may benefit from this test.
The test involves analyzing a sample of your blood or saliva using Next Generation Sequencing (NGS) technology to look for specific changes in the DSG1 gene.
Results indicate whether specific mutations associated with keratosis palmoplantaris striata type 1 were found in the DSG1 gene. A healthcare provider or genetic counselor will help interpret the results.
Genetic counseling is recommended to discuss the test results and their implications, but it may be arranged separately. Please inquire for details.
Turnaround time varies. Please confirm the current estimated time with the laboratory before booking your test.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp